Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

Hepatic Arterial Infusion Therapy for CRC Liver Mets and Unresectabl…

Yale Cancer Center

J. Kortmansky, S. Khan

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

ESMO 2024 Insights: The Value of Immune Checkpoint Blockade in MSS/p…

2024 ESMO Annual Meeting Insights Hub

B. Geisler

How Recent Data Impacts Colon and Rectal Cancer Treatment Decisions

Integrity CE

D. Mulkerin, S. Mukherjee

Anti-EGFR Therapy in CRC: How to Manage Toxicities

Ibrahim Sahin

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSM…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

Treating KRAS-Mutated mCRC

Ibrahim Sahin

Guidance on Incorporating Anti-EGFR Therapy in 1L CRC Practice

Ibrahim Sahin

mCRC Case Discussion: Treatment Options for Unresectable Liver Metas…

Yale Cancer Center

P. Kunz, L. Baum, K. Du, S. Khan, J. Kortmansky

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey